Additionally, in the current study we show a correlation of low expression of AR in tumors with ILK cytoplasmic overexpression (r = −0.260, P = 0.01) which possibly suggests an interaction of those molecules in laryngeal cancer, yet not in line with the hypothesis of ARs being activated by ILK. The gene discussed is ILK; the disease is laryngeal carcinoma.